Harrow Stock

Harrow EBITDA per Employee

The EBITDA per Employee of Harrow (HROW) as of Aug 4, 2026 is 308,872.00 USD. In the previous year, EBITDA per Employee was 70,576.00 USD — a change of 337.64% (higher).

EBITDA per Employee

308,872.00USD

YoY

337.64%

Last updated:

EBITDA per Employee of Harrow is 2026 308,872.00 USD. EBITDA per Employee of Harrow was 2025 70,576.00 USD. It decreases by 337.64% higher compared to the previous year.
Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

EBITDA per Employee of Harrow is 308,872.00 USD in 2026.

EBITDA per Employee of Harrow changed from 70,576.00 USD to 308,872.00 USD, representing a 337.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Harrow since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Harrow historically and in real time.

Access this data via the Eulerpool API

Workforce — Harrow

All Key Metrics — Harrow